Bioactivity-Guided Fraction from Viscera of Abalone, Haliotis discus hannai Suppresses Cellular Basophils Activation and Anaphylaxis in Mice
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Basophils and mast cells are specialized effector cells in allergic reactions. Haliotis discus hannai (abalone), is valuable seafood. Abalone male viscera, which has a brownish color and has not been previously reported to show anti-allergic activities, was extracted with acetone. Six different acetone/hexane fractions (0, 10, 20, 30, 40, and 100%) were obtained using a silica column via βhexosaminidase release inhibitory activity-guided selection in phorbol myristate acetate and a calcium ionophore, A23187 (PMACI)-induced human basophils, KU812F cells. The 40% acetone/ hexane fraction (A40) exhibited the strongest inhibition of PMACI-induced-β-hexosaminidase release. This fraction dose-dependently inhibited reactive oxygen species (ROS) production and calcium mobilization without cytotoxicity. Western blot analysis revealed that A40 down-regulated PMACI-induced MAPK (ERK 1/2, p-38, and JNK) phosphorylation, and the NF-κB translocation from the cytosol to membrane. Moreover, A40 inhibited PMACI-induced interleukin (IL)-1β, IL-6, and IL-8 production. Anti-allergic activities of A40 were confirmed based on inhibitory effects on IL-4 and tumor necrosis factor alpha (TNF-α) production in compound (com) 48/80-induced rat basophilic leukemia (RBL)-2H3 cells. A40 inhibited β-hexosaminidase release and cytokine production such as IL-4 and TNF-α produced by com 48/80-stimulated RBL-2H3 cells. Furthermore, it’s fraction attenuated the IgE/DNP-induced passive cutaneous anaphylaxis (PCA) reaction in the ears of BALB/c mice. Our results suggest that abalone contains the active fraction, A40 is a potent therapeutic and functional material to treat allergic diseases.
Abstract
Basophils and mast cells are specialized effector cells in allergic reactions. Haliotis discus hannai (abalone), is valuable seafood. Abalone male viscera, which has a brownish color and has not been previously reported to show anti-allergic activities, was extracted with acetone. Six different acetone/hexane fractions (0, 10, 20, 30, 40, and 100%) were obtained using a silica column via βhexosaminidase release inhibitory activity-guided selection in phorbol myristate acetate and a calcium ionophore, A23187 (PMACI)-induced human basophils, KU812F cells. The 40% acetone/ hexane fraction (A40) exhibited the strongest inhibition of PMACI-induced-β-hexosaminidase release. This fraction dose-dependently inhibited reactive oxygen species (ROS) production and calcium mobilization without cytotoxicity. Western blot analysis revealed that A40 down-regulated PMACI-induced MAPK (ERK 1/2, p-38, and JNK) phosphorylation, and the NF-κB translocation from the cytosol to membrane. Moreover, A40 inhibited PMACI-induced interleukin (IL)-1β, IL-6, and IL-8 production. Anti-allergic activities of A40 were confirmed based on inhibitory effects on IL-4 and tumor necrosis factor alpha (TNF-α) production in compound (com) 48/80-induced rat basophilic leukemia (RBL)-2H3 cells. A40 inhibited β-hexosaminidase release and cytokine production such as IL-4 and TNF-α produced by com 48/80-stimulated RBL-2H3 cells. Furthermore, it’s fraction attenuated the IgE/DNP-induced passive cutaneous anaphylaxis (PCA) reaction in the ears of BALB/c mice. Our results suggest that abalone contains the active fraction, A40 is a potent therapeutic and functional material to treat allergic diseases.
참고문헌 (32)
- Gershwin LJ, "Comparative immunology of allergic responses", Annu. Rev. Anim. Biosci, 3, pp.327~346 (2015)
- Jiménez-Andrade GY, "Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism", J. Hematol. Oncol, 6, pp.56~ (2013)
- Galli SJ, "The development of allergic inflammation", Nature, 454, pp.445~454 (2008)
- Stone KD, "IgE, mast cells, basophils, and eosinophils", J. Allergy Clin. Immunol, 125, pp.S73~S80 (2010)
- Shao-heng HE, "Mast cells and basophils are essential for allergies : mechanisms of allergic inflammation and a proposed procedure for diagnosis", Acta Pharmacol. Sin, 34, pp.1270~1283 (2013)
- Galli SJ, "Cytokine production by mast cells and basophils", Curr. Opin. Immunol, 3, pp.865~872 (1991)
- Valent P, "Mast cell activation syndromes : collegium internationale allergologicum update 2022", J. Allergy Clin. Immunol, 183, pp.693~705 (2022)
- Ngoc PL, "Cytokines, allergy, and asthma", Curr. Opin. Allergy Clin. Immunol, 5, pp.161~166 (2005)
- Finkel T, "Signal transduction by reactive oxygen species", J. Cell Biol, 194, pp.7~15 (2011)
- Swindle EJ, "A comparison of reactive oxygen species generation by rat peritoneal macrophages and mast cells using the highly sensitive real-time chemiluminescent probe pholasin : inhibition of antigen-induced mast cell degranulation by macrophage derived hydrogen peroxide", J. Immunol, 169, pp.5866~5873 (2002)
- Morris G, "Redox regulation of the immune response", Cell. Mol. Immunol, 19, pp.1079~1101 (2022)
- Berridge MJ, "Inositol trisphosphate and calcium signaling", Nature, 361, pp.315~325 (1993)
- Whitmarsh AJ, "Regulation of gene transcription by mitogen-activated protein kinase signaling pathways", Biochim. Biophys. Acta, 1773, pp.1285~1298 (2007)
- Yeung YT, "Signaling pathways in inflammation and anti-inflammatory therapies", Curr. Pharm. Des, 24, pp.1449~1484 (2018)
- Zhao H, "Inflammation and tumor progression : signaling pathways and targeted intervention", Signal Transduct. Target. Ther, 6, pp.263~ (2021)
- Zhou DA, "Simultaneous recovery of protein and polysaccharide from abalone(Haliotis discus hannai Ino)gonad using enzymatic hydrolysis method", J. Food Process. Preserv, 40, pp.119~130 (2016)
- Guo S, "Preparation and antioxidant activities of polysaccharides obtained from abalone viscera by combination of enzymolysis and multiple separation methods", J. Food Sci, 85, pp.4260~4270 (2020)
- Gong F, "Boiled abalone byproduct peptide exhibits anti-tumor activity in HT1080Cells and HUVECs by suppressing the metastasis and angiogenesis in Vitro", J. Agric. Food Chem, 67, pp.8855~8867 (2019)
- Suleria HAR, "Therapeutic potential of abalone and status of bioactive molecules : a comprehensive review", Crit. Rev. Food Sci. Nutr, 57, pp.1742~1748 (2017)
- Shin TS, "Antiinflammatory effects of abalone (Haliotis discus hannai) viscera via inhibition of ROS production in LPS-stimulated RAW264.7 cells", Microbiol. Biotechnol. Lett, 50, pp.22~30 (2022)
- Choi KS, "Sargahydroquinoic acid isolated from Sargassum serratifolium as inhibitor of cellular basophils activation and passive cutaneous anaphylaxis in mice", Int. Immunopharmacol, 105, pp.108567~ (2022)
- Evans H, "Measuring local anaphylaxis in mice", J. Vis. Exp, 92, pp.e52005~e52005 (2014)
- Plaut M, "Mast cell lines produce lymphokines in response to crosslinkage of Fc epsilon RI or to calcium ionophores", Nature, 339, pp.64~67 (1989)
- Kaur G, "Role of oxidative stress in pathophysiology of rheumatoid arthritis : insights into NRF2-KEAP1 signalling", Autoimmunity, 54, pp.385~397 (2021)
- Gilfillan AM, "The tyrosine kinase network regulating mast cell activation", Immunol. Rev, 228, pp.149~169 (2009)
- Siraganian RP, "Mast cell signaling : the role of protein tyrosine kinase syk, its activation and screening methods for new pathway participants", FEBS Lett, 584, pp.4933~4940 (2010)
- Geldman A, "Protein tyrosine phosphatases in mast cell signaling", Methods Mol. Biol, 1220, pp.269~286 (2014)
- Sibilano R, "Mast cell activation : a complex interplay of positive and negative signaling pathways", Eur. J. Immunol, 44, pp.2558~2566 (2014)
- Nigrovic PA, "Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1", Proc. Natl. Acad. Sci. USA, 104, pp.2325~2330 (2007)
- Lype J, "IL-1β promotes immunoregulatory responses in human blood basophils", Allergy, 76, pp.2017~2029 (2021)
- Galli SJ, "Mast cells in inflammation and disease : recent progress and ongoing concerns", Annu. Rev. Immunol, 38, pp.49~77 (2020)
- Metcalfe DD, "Mechanisms of mast cell signaling in anaphylaxis", J. Allergy Clin. Immunol, 124, pp.639~946 (2009)